Bioactive Natural and Synthetic Saccharides against Human Diseases
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Biochemistry, Molecular and Cellular Biology".
Deadline for manuscript submissions: closed (30 September 2024) | Viewed by 1725
Special Issue Editor
2. AyuVis Research, Fort Worth, TX 76107, USA
Interests: anti-inflammation/anti-oxidant pathways; novel therapeutic molecules; synthetic saccharides; drug delivery
Special Issue Information
Dear Colleagues,
Bioactive oligosaccharides are oligosaccharide molecules with specific structures and functions, synthesized or derived from natural sources. Due to their natural occurrence, non-toxic nature and biodegradability, low-molecular-weight natural oligosaccharides (e.g., chitosan and its derivatives from chitosan and chitin polymers) have attracted much attention as therapeutic candidates for a variety of diseases. Many studies have demonstrated their potential benefits in the prevention and treatment of a variety of diseases in terms of intestinal health, anti-microbial activity, immunomodulation, antioxidant, metabolic regulation and bone density protection. They also provide directions for future research and clinical practice.
In this Special Issue, we would like to emphasize the importance of natural and synthetic oligosaccharides in the prevention and treatment of human diseases. Therefore, we strongly encourage researchers to present their significant research/clinical findings to demonstrate the great biological potential of this class of natural products.
Dr. Suchismita Acharya
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- naturally and synthetically occurring saccharides
- intestinal health
- anti-microbial activity
- immunomodulation
- antioxidant
- metabolic regulation
- neuroprotection
- lung injury
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
